Tear film-mucous layer dysfunction and pathogenesis of diabetes-associated dry eye disease

Information

  • Research Project
  • 9656496
  • ApplicationId
    9656496
  • Core Project Number
    R15EY029098
  • Full Project Number
    1R15EY029098-01A1
  • Serial Number
    029098
  • FOA Number
    PA-18-504
  • Sub Project Id
  • Project Start Date
    3/1/2019 - 6 years ago
  • Project End Date
    2/28/2022 - 3 years ago
  • Program Officer Name
    MCKIE, GEORGE ANN
  • Budget Start Date
    3/1/2019 - 6 years ago
  • Budget End Date
    2/28/2022 - 3 years ago
  • Fiscal Year
    2019
  • Support Year
    01
  • Suffix
    A1
  • Award Notice Date
    2/27/2019 - 6 years ago
Organizations

Tear film-mucous layer dysfunction and pathogenesis of diabetes-associated dry eye disease

Project Summary/Abstract It has long been known that diabetes mellitus causes damage to the retina and lens. Recent evidence suggests that diabetes also affects tear film and causes dry eye. The long-term goal of the project is to understand how diabetes mellitus causes dry eye disease with the intention to identify mechanism-based therapeutic approaches for its treatment or prevention. A normal tear film has lipid, aqueous and mucous layer contributed by meibomian glands, lacrimal gland and ocular surface cells, respectively. Diabetes-mediated abnormality in any of the three layers individually or collectively can cause dry eye. The specific goal of the current application is to determine how diabetes mellitus alters mucous layer of the tear film to cause dry eye disease. Mouse models of type I and type II diabetes will be utilized in this proposal to quantify the time course changes in tear secretion, tear osmolarity and ocular surface glycocalyx integrity. Apoptosis of corneal and conjunctival epithelial cells and a decrease in goblet cell density due to diabetes mellitus will also be measured in the tissues obtained from these mice. Mucins will be quantified by ELISA in the tears obtained from these mice. Mucins gene expression will be quantified by real time PCR using the cDNA obtained from the cultured human corneal and conjunctival epithelial cells exposed to high glucose. Finally, mice will be given insulin to maintain normal blood glucose levels right at the onset of diabetes or at 4 weeks after diabetes. The outcome of these experiments will reveal how glycemic control modifies dry eye disease course due to diabetes mellitus.

IC Name
NATIONAL EYE INSTITUTE
  • Activity
    R15
  • Administering IC
    EY
  • Application Type
    1
  • Direct Cost Amount
    299767
  • Indirect Cost Amount
    110491
  • Total Cost
    410258
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    867
  • Ed Inst. Type
    SCHOOLS OF PHARMACY
  • Funding ICs
    NEI:410258\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    CHAPMAN UNIVERSITY
  • Organization Department
    PHARMACOLOGY
  • Organization DUNS
    072528433
  • Organization City
    ORANGE
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    928661005
  • Organization District
    UNITED STATES